Mingxia Liu

机构：Sichuan University, West China Hospital of Sichuan University, Beijing Anding Hospital · ORCID：0000-0001-5853-904X

发表论文 25 篇 · 总被引 335 次 · h-index 9

代表论文

• miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1 (2016 · Oncotarget · 被引 95)
• Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis (2012 · Journal of Lipid Research · 被引 43)
• Hepatic ABCA1 and VLDL triglyceride production (2011 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 被引 41)
• Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor (2019 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 36)
• Myeloid Cell–Specific ATP-Binding Cassette Transporter A1 Deletion Has Minimal Impact on Atherogenesis in Atherogenic Diet–Fed Low-Density Lipoprotein Receptor Knockout Mice (2014 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 32)
• Large volume acute normovolemic hemodilution in patients undergoing cardiac surgery with intermediate-high risk of transfusion: A randomized controlled trial (2023 · Journal of Clinical Anesthesia · 被引 18)